Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> New Publication <<
August 18, 2025
Conflicts of interest in federal vaccine advisory committees. [PDF] JAMA 2025. Online ahead of print.
>> New Publication <<
July 31, 2025
Impact of the MISSION Act on quality and outcomes of major cardiovascular procedures among veterans. JAMA 2025. Online ahead of print.
Public Comment
August 13, 2024
Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]
New York Times
August 22, 2025
Covid vaccine opponent tapped to lead federal review team [PDF]
by Christina Jewett
Reuters
August 18, 2025
Vaccine panel fired by Kennedy had lowest rate of financial conflicts since 2000, study shows
by Nancy Lapid
AP
August 18, 2025
FDA’s new expert panels are rife with financial conflicts and fringe views
by Matthew Perrone